Tajbakhsh, Kiarash
Stanowska, Olga
Buljan, Marija
Neels, Antonia
Perren, Aurel
Zboray, Robert
Funding for this research was provided by:
Empa - Swiss Federal Laboratories for Materials Science and Technology
Article History
Received: 17 October 2025
Accepted: 9 June 2026
First Online: 17 June 2026
Declarations
:
: Tissue Biobank Bern (TBB) manages ngTMAs and patient information according to respective regulations and fulfills the Swiss Biobanking Platform requirements. The Institute of Tissue Medicine and Pathology (ITMP) of the University of Bern provided the ngTMAs and pseudonymized patient data from the TBB according to the protocol approved by the cantonal ethics commission (KEKBE 2018-01657). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects.
: The authors declare no competing interests.